The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

HCA Holdings Inc

NYSE: HCA
Last

(U.S.) $69.19

Today's change-0.94 -1.34%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.
 

HCA Holdings Inc

NYSE: HCA
Last

(U.S.) $69.19

Today's change-0.94 -1.34%
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

HCA Holdings Inc down (U.S.)$0.94

HCA Holdings Inc closed lower Friday, dropping (U.S.)$0.94 or 1.34% to (U.S.)$69.19. Shares have lost 0.56% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P 500 by 9.34% during the last year.

Key company metrics

  • Open(U.S.) $70.13
  • Previous close(U.S.) $70.13
  • High(U.S.) $71.20
  • Low(U.S.) $68.80
  • Bid / Ask-- / --
  • YTD % change+2.31%
  • Volume3,465,051
  • Average volume (10-day)4,345,316
  • Average volume (1-month)4,145,868
  • Average volume (3-month)4,540,163
  • 52-week range(U.S.) $43.91 to (U.S.) $95.49
  • Beta1.05
  • Trailing P/E13.86×
  • P/E 1 year forward11.06×
  • Forward PEG1.10×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.99
Updated February 5 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+6.79%

Based on its net profit margin of 6.79%, HCA Holdings Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.08%Sector:HealthcareIndustry:Healthcare Facilities

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue10,2499,8569,8979,676
Total other revenue--------
Total revenue10,2499,8569,8979,676
Gross profit8,5638,2128,2278,038
Total cost of revenue1,6861,6441,6701,638
Total operating expense8,7888,6098,4938,207
Selling / general / administrative6,4416,4156,2476,115
Research & development--------
Depreciation / amortization480482469473
Interest expense (income), net operating--------
Unusual expense (income)18277125--
Other operating expenses, total-1-9-18-19
Operating income1,4611,2471,4041,469
Interest income (expense), net non-operating-410-411-425-419
Gain (loss) on sale of assets-7-2-59
Other--------
Income before tax1,0528439841,078
Income after tax738573665720
Income tax, total314270319358
Net income582449507591
Total adjustments to net income--------
Net income before extra. items582449507591
Minority interest-156-124-158-129
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items582449507591
Inc. avail. to common incl. extra. items582449507591
Diluted net income582449507591
Dilution adjustment--------
Diluted weighted average shares416426429435
Diluted EPS excluding extraordinary itemsvalue per share1.401.051.181.36
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share1.721.181.391.34